New Data Highlights CDC’s Contributions

The latest data from the Division of Global HIV & TB highlight CDC’s contributions toward global efforts to control the HIV and TB epidemics. CDC, as an implementing agency of the U.S. President’s Emergency Plan for AIDS Relief, is working with partnersCdc-pdf to drive progress in HIV prevention and treatment and help some of the world’s most affected countries accelerate progress towards epidemic control. The new data add to findings released in the past two years, which show that six African countries are approaching control of their HIV epidemics. HIV and TB are the world’s two most deadly infectious diseases. TB is also the leading cause of death for people living with HIV. CDC works in more than 40 high-burden countries to find, cure and prevent TBCdc-pdf. We’re also tackling HIV and TB together for greatest impact. See below – through stories and data – how CDC is making an impact in the global fight against HIV and TB and saving lives.


Cdc-pdf

Download the DGHT Impact FlowchartCdc-pdf

Infographic details

 

PATHWAY TO HIV & TB EPIDEMIC CONTROL

This is the story of how everyday people help keep the world on the pathway to controlling the HIV and TB epidemic.

Each morning Thabiso passes a billboard for HIV testing. Today he considers if he has been honest with himself about his HIV risk. He does not know his HIV status, and decides it is time he gets tested.

Through free rapid testing at a clinic, Thabiso learns he is HIV positive. He is scared of what this means for him, and his family – his wife Margaret is pregnant with their second child andhas never been tested for HIV.

The health worker tells Thabiso that the best way to stay healthy is to start HIV medication right away – and he agrees. Thabiso knows that he must now stay strong and tell Margaret his status, so that she may also get tested.

The next day Thabiso goes with Margaret to the antenatal clinic, where she gets tested and learns she is HIV positive. They listen carefully to the nurse explain how they can best protect their unborn baby.

During enrollment at the clinic, the health worker also screens Thabiso for TB – he is told he has no symptoms, and he agrees to start TB preventive therapy.

Because Thabiso and Margaret do not know when they got HIV, the nurse advises them to get their older child tested. When their child’s HIV test result is positive, they immediately start her on HIV treatment – and on TB preventive therapy, because the nurse did not find symptoms.

Thabiso worries that, like him and his family, his friends may underestimate their HIV risk. He tells them his story to encourage them to get tested. One friend says his doctor at the TB clinic tested him for HIV – and he is also HIV positive.

Another friend has an appointment at the male circumcision clinic, but shares that he has never been tested for HIV. After Thabiso’s story, he decides he should also get tested while at the clinic.

He tells Thabiso and the others that he has kept himself healthy by taking all of his HIV and TB medications.

At one of their check-ups, the nurse offers Margaret and her family a test to see how well their bodies and the

Medicine are fighting the HIV. When Margaret asks if the test really works, the nurse tells her about the laboratory’s dedication to ensuring the quality of all tests for HIV.

Margaret, Thabiso and their daughter are given the test and are told that there is very little HIV in their blood because of their commitment to staying on lifelong medication. The nurse explains that the less HIV there is, the more likely they will lead healthier lives and the less likely the virus will be transmitted. She tells them that they should be proud, and urges them to remain on this successful path.

Thabiso, Margaret and their daughter keep taking their medication, and Margaret gives birth at a facility. Their new baby tests negative for HIV within his first two months – but they know he must be tested again. The second test, given after Margaret stops breastfeeding, confirms that their new son is HIV NEGATIVE!

They agree to do what is necessary, and Margaret starts HIV medication immediately. She screened negative for TB, so also starts TB preventive therapy. Margaret vows to stay on the medication, and give birth at the health facility, so the new baby can be given preventative HIV medicine once born.

Data above reflect FY2017 annual results, with the exception of the indicators for VMMC and currently on treatment. VMMC is cumulative as of September 30, 2017 and currently on treatment is as of September 30, 2017. All data were sourced from the US President’s Emergency Plan for AIDS Relief (PEPFAR).

By taking each step on this path, Thabiso, Margaret and their friends joined the millions of others who have contributed to saving lives through achieving epidemic control. The following are CDC’s contributions to global HIV and TB control efforts as part of PEPFAR.

 

PEOPLE TESTED FOR HIV

CDC: 49.7M | PEPFAR: 85.5M

 

PREGNANT WOMEN WHO KNOW THEIR HIV STATUS

CDC: 7M | PEPFAR: 11.4M

 

TB PATIENTS WHO KNOW THEIR STATUS

CDC: 405K | PEPFAR: 735K

 

HIV-POSITIVE PEOPLE STARTED ON ANTIRETROVIRAL TREATMENT

CDC: 1.5M | PEPFAR: 3.3M

 

HIV-POSITIVE PEOPLE CURRENTLY ON ANTI-RETROVIRAL TREATMENT

CDC: 7.3M | PEPFAR: 13.3M

 

HIV-POSITIVE PREGNANT WOMEN ON ANTIRETROVIRAL TREATMENT TO PREVENT MOTHER-TO-CHILD TRANSMISSION

CDC: 453K | PEPFAR: 792K

 

HIV-POSITIVE TB PATIENTS ON ANTIRETROVIRAL TREATMENT

CDC: 135K | PEPFAR: 252K

 

HIV-POSITIVE PEOPLE IN CARE WHO HAVE BEEN SCREENED FOR TB

CDC: 4.7M | PEPFAR: 7M

 

VOLUNTARY MEDICAL MALE CIRCUMCISIONS TO REDUCE THE RIST OF HIV TRANSMISSION

CDC: 7.5M | PEPFAR: 15.2M

 

NUMBER OF TESTING FACILITIES WITH CAPACITY TO PERFORM CLINICAL LAB TESTS

CDC: 13K | PEPFAR: 15K

Page last reviewed: January 25, 2019, 11:30 AM